Prime Medicine, Inc. Common Stock (PRME) Stock Analysis

Prime Medicine, Inc. Common Stock (PRME) is a publicly traded company in the HEALTHCARE sector. It trades at $3.21, carries a market capitalization of $614.10M. This page summarizes the public market data, fundamentals, and frequently asked questions for PRME, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.21
• Market Cap: $614.10M
• EPS: $-1.23
• 52-Week High: $6.94
• 52-Week Low: $1.29

Market Sentiment

Prime Medicine, Inc. Common Stock currently has a Bullish sentiment score of 0.26.

About Prime Medicine, Inc. Common Stock

None

GNG Research Analysis

GNG Research scores Prime Medicine, Inc. Common Stock (PRME) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PRME.

Frequently Asked Questions

Does PRME pay dividends?

Prime Medicine, Inc. Common Stock (PRME) does not currently pay a regular dividend.

What is PRME's market cap?

Prime Medicine, Inc. Common Stock (PRME) has a market capitalization of $614.10M with a current stock price of $3.21.